RxDoctor Payments Data

Heather Korkowski, APRN

Family · Melbourne, FLNPI 1922626647

Payments from drug & device makers

$2,172in general payments, 2019–2025

Across 123 payments — averaging $17.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$559
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$332
  • Phathom Pharmaceuticals, Inc.$239
  • Takeda Pharmaceuticals U.S.A., Inc.$176
  • Ironwood Pharmaceuticals, Inc$173
  • Evoke Pharma, Inc.$164
  • plus $529 from 11 others

What the payments were for

  • Food & beverage$2,15899%
  • Education$141%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,172 in reported general payments places this provider in the 80th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$11,749
Medicare patients
85
Services billed
123

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CreonLipase/Protease/Amylase39$170,847
LinzessLinaclotide60$64,816
GimotiMetoclopramide Hcl13$26,689
TrulancePlecanatide27$16,339
Dicyclomine Hcl104$4,124
Esomeprazole Magnesium96$3,931
Sucralfate155$3,917
Ondansetron Hcl24$2,784
Mesalamine ErMesalamine13$2,631
Famotidine145$1,570
Colestipol Hcl21$1,420
CholestyramineCholestyramine (With Sugar)19$897
Omeprazole82$865
Ondansetron OdtOndansetron11$839
Pantoprazole Sodium73$683

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieCreon, Linzess$559$235,66399 claims
Evoke Pharma, Inc.Gimoti$164$26,68913 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance$332$16,33927 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 14,618 family providers in Florida.

Other family in Melbourne

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →